Completely agree!! The register should be much tighter as well, and with clinical trials progressing to the final stages we are in a very exciting time for the company and shareholders. 2024 is poised to be a big year!
Cheers
EMvision Research Notes, page-2227
Add EMV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.00 |
Change
0.090(4.71%) |
Mkt cap ! $170.8M | |||
| Open | High | Low | Value | Volume |
| $1.98 | $2.00 | $1.95 | $41.09K | 20.85K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25 | $1.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.00 | 561 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.00 |
Change
0.090 ( 3.05 %) |
||||
| Open | High | Low | Volume | ||
| $1.98 | $2.00 | $1.95 | 7083 | ||
| Last updated 15.59pm 17/06/2024 ? | |||||
| EMV (ASX) Chart |
